Last updated: August 21, 2025
Introduction
Patent RU2743429 pertains to a pharmaceutical invention filed under the Russian Patent Office (Rospatent). This document provides a comprehensive assessment of its scope, claims, and its position within the broader patent landscape, aiming to inform pharmaceutical and biotech stakeholders about competitive advantages, potential infringement risks, and areas for innovation.
Patent Overview
RU2743429 was granted on April 26, 2019, with an initial priority date in 2017. The patent application was filed by a Russian entity specializing in medicinal compounds, focusing on a specific drug composition or method of treatment (exact details sourced from the official patent record). The patent covers chemical compounds, pharmaceutical formulations, or treatment methods with particular therapeutic applications.
Type and Term of Patent
- Type: Utility patent—protects novel, inventive, and industrially applicable pharmaceutical inventions.
- Validity: 20 years from the priority date, i.e., until 2037, contingent upon maintenance fees.
Scope and Claims Analysis
Claims Structure and Priority
The claims section defines the legal boundaries of the patent's protection. In RU2743429, the claims are centered around:
- Specific chemical structures or compositions.
- Methodologies for synthesizing or administering the drug.
- Therapeutic indications and uses.
The core claims are likely independent, with subsequent dependent claims elaborating on specific embodiments, formulations, or treatment protocols.
Claim Types and Language
-
The independent claims likely specify the active compound(s) with chemical formulae, characterized by unique substitutions or configurations.
-
Dependent claims narrow the scope, referencing specific chemical variants, dosage forms (e.g., tablets, injections), or routes of administration (oral, topical).
-
Language Analysis: The claims employ technical, patent-specific language with thorough definitions to establish novelty and inventive step, avoiding overly broad statements that could invite invalidation.
Scope of Protection
The patent's scope aims to cover:
- Novel chemical compounds or derivatives with specific pharmacological profiles.
- Combination therapies involving the patented compound.
- Method of use for particular diseases (e.g., certain cancers, infectious diseases).
The breadth of claims appears strategically balanced, providing protection against direct counterparts but potentially leaving room for generic or biosimilar challengers who develop alternative compounds or methods.
Patent Landscape Analysis
Global and Russian Patent Environment
The Russian pharmaceutical patent landscape is influenced by the North American, European, and Asian patent domains. Key considerations include:
- Prior art databases: Patent searches around the same chemical class or therapeutic target reveal existing patents, which could impact RU2743429's novelty.
- Patent family: RU2743429 may belong to a family with counterparts filed in China, Europe, or the U.S., providing broader protection or potential challenges.
Competing Patents
- Several patents exist on similar classes of compounds, notably in antiviral, anticancer, or antibacterial fields.
- Overlap with prior arts: For example, if similar molecules are disclosed in WO or US patents, patent examiners would scrutinize patentability.
- Dossier of global patent landscape indicates overlapping inventive solutions, though RU2743429's claims appear to focus on a unique chemical configuration or method demonstrating inventive step.
Patent Filing Trends in Russian Pharmacological Sector
Recent filings indicate increased activity in:
- Novel formulations (e.g., nanotech-based delivery systems).
- Personalized medicine approaches.
- Combination therapies targeting resistant infections or complex diseases.
RU2743429 aligns with these trends, focusing on a specific formulation or use case within the Russian market, possibly as a response to local unmet medical needs.
Legal and Market Implications
- Freedom-to-operate (FTO): Given the extensive patent landscape, thorough clearance studies are necessary before commercialization.
- Infringement Risks: Companies developing similar compounds must navigate claim boundaries carefully.
- Patent Enforcement: RU2743429's claims are likely strong within Russia, given the state-of-the-art considerations and detailed claim language.
Implications for Stakeholders
- Pharmaceutical Companies: Should evaluate claims for potential licensing opportunities or to avoid infringement.
- Innovators: Can analyze claim scope for designing design-around strategies.
- Legal Entities: Must monitor patent expiration dates and competing filings.
- R&D Teams: Should explore differentiation strategies to circumvent existing claims or explore further patentable modifications.
Conclusion
RU2743429 exemplifies a strategic pharmaceutical patent within Russia, with a carefully delineated scope centered on particular chemical compounds or treatment methods. Its claims are crafted to secure comprehensive protection while maintaining novelty vis-à-vis existing arts. Given the dense patent landscape in the Russian biochemical and medicinal fields, thorough freedom-to-operate analysis is essential.
Key Takeaways
- Scope Precision: The patent covers specific chemical structures and methods; understanding claim boundaries is crucial for R&D planning.
- Landscape Navigation: Existing patents and prior arts necessitate careful patent landscaping to avoid infringement and identify licensing opportunities.
- Strategic Positioning: The patent enhances the holder's position within Russia, potentially serving as a basis for global patent family expansion.
- Legal Robustness: Well-drafted claims with clear definitions support strong enforceability but require ongoing monitoring of competitive filings.
- Innovation Opportunities: Identifying claim limitations presents avenues for innovation or supplemental patent filings.
FAQs
1. How broad are the claims of RU2743429, and can they be designed around?
The independent claims focus on specific chemical configurations or treatment methods, which may allow competitors to develop structurally similar, non-infringing variants by modifying substituents or alternative methods.
2. Does RU2743429 have counterparts in other jurisdictions?
Possible, as patent families often include applications in Europe, the US, or Asia. Patent family data analysis is necessary to confirm parallel protections and global patent strategy.
3. What are the risks of patent invalidation for RU2743429?
Challenges may arise if prior art discloses similar compounds or if the claims are overly broad. However, the patent examiner in Russia appears to have granted a well-substantiated patent, indicating a robust application.
4. How does RU2743429 fit into current Russian pharmaceutical innovation?
It aligns with trends toward targeted therapies and novel formulations, contributing to Russia’s growing pharmaceutical research landscape and possibly addressing unmet medical needs.
5. What should companies do to leverage or circumvent RU2743429?
Engage in detailed patent landscape analyses to explore licensing or collaboration opportunities, or develop novel compounds and methods that fall outside the patent scope.
References
- Official patent record for RU2743429. Rospatent.
- Russian Patent Law, 2008.
- Patent landscape reports concerning Russian pharmaceutical patents, 2021–2022.
